FDA Drug Application (204042) for INVOKANA by JANSSEN PHARMS

Back to FDA Applications sponsored by JANSSEN PHARMS

Application Number204042
Product Number001
FormTABLET;ORAL
Dosage100MG
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code
Reference Drug
Drug NameINVOKANA
Active IngredientCANAGLIFLOZIN

Active IngredientCount
List of drugs with Active Ingredient CANAGLIFLOZIN3


Back to FDA Applications sponsored by JANSSEN PHARMS